These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

139 related articles for article (PubMed ID: 34880312)

  • 61. Vascular endothelial growth factor overexpression delays neurodegeneration and prolongs survival in amyotrophic lateral sclerosis mice.
    Wang Y; Mao XO; Xie L; Banwait S; Marti HH; Greenberg DA; Jin K
    J Neurosci; 2007 Jan; 27(2):304-7. PubMed ID: 17215390
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Pathophysiological role of prostaglandin E2-induced up-regulation of the EP2 receptor in motor neuron-like NSC-34 cells and lumbar motor neurons in ALS model mice.
    Kosuge Y; Miyagishi H; Yoneoka Y; Yoneda K; Nango H; Ishige K; Ito Y
    Neurochem Int; 2018 Oct; 119():132-139. PubMed ID: 28687401
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Widespread aggregation of mutant VAPB associated with ALS does not cause motor neuron degeneration or modulate mutant SOD1 aggregation and toxicity in mice.
    Qiu L; Qiao T; Beers M; Tan W; Wang H; Yang B; Xu Z
    Mol Neurodegener; 2013 Jan; 8():1. PubMed ID: 23281774
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Bone-marrow mononuclear cell therapy in a mouse model of amyotrophic lateral sclerosis: Functional outcomes from different administration routes.
    Gubert F; Bonacossa-Pereira I; Decotelli AB; Furtado M; Vasconcelos-Dos-Santos A; Mendez-Otero R; Santiago MF
    Brain Res; 2019 Jun; 1712():73-81. PubMed ID: 30735638
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Single-cell RNA-seq analysis of the brainstem of mutant SOD1 mice reveals perturbed cell types and pathways of amyotrophic lateral sclerosis.
    Liu W; Venugopal S; Majid S; Ahn IS; Diamante G; Hong J; Yang X; Chandler SH
    Neurobiol Dis; 2020 Jul; 141():104877. PubMed ID: 32360664
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Microglial keratan sulfate epitope elicits in central nervous tissues of transgenic model mice and patients with amyotrophic lateral sclerosis.
    Foyez T; Takeda-Uchimura Y; Ishigaki S; Narentuya ; Zhang Z; Sobue G; Kadomatsu K; Uchimura K
    Am J Pathol; 2015 Nov; 185(11):3053-65. PubMed ID: 26362733
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Targeting miR-155 restores abnormal microglia and attenuates disease in SOD1 mice.
    Butovsky O; Jedrychowski MP; Cialic R; Krasemann S; Murugaiyan G; Fanek Z; Greco DJ; Wu PM; Doykan CE; Kiner O; Lawson RJ; Frosch MP; Pochet N; Fatimy RE; Krichevsky AM; Gygi SP; Lassmann H; Berry J; Cudkowicz ME; Weiner HL
    Ann Neurol; 2015 Jan; 77(1):75-99. PubMed ID: 25381879
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Inhibition of collapsin response mediator protein-2 phosphorylation ameliorates motor phenotype of ALS model mice expressing SOD1G93A.
    Numata-Uematsu Y; Wakatsuki S; Nagano S; Shibata M; Sakai K; Ichinohe N; Mikoshiba K; Ohshima T; Yamashita N; Goshima Y; Araki T
    Neurosci Res; 2019 Feb; 139():63-68. PubMed ID: 30194029
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Differential screening of mutated SOD1 transgenic mice reveals early up-regulation of a fast axonal transport component in spinal cord motor neurons.
    Dupuis L; de Tapia M; René F; Lutz-Bucher B; Gordon JW; Mercken L; Pradier L; Loeffler JP
    Neurobiol Dis; 2000 Aug; 7(4):274-85. PubMed ID: 10964600
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Increased mitochondrial antioxidative activity or decreased oxygen free radical propagation prevent mutant SOD1-mediated motor neuron cell death and increase amyotrophic lateral sclerosis-like transgenic mouse survival.
    Liu R; Li B; Flanagan SW; Oberley LW; Gozal D; Qiu M
    J Neurochem; 2002 Feb; 80(3):488-500. PubMed ID: 11905995
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Neuregulin 1 confers neuroprotection in SOD1-linked amyotrophic lateral sclerosis mice via restoration of C-boutons of spinal motor neurons.
    Lasiene J; Komine O; Fujimori-Tonou N; Powers B; Endo F; Watanabe S; Shijie J; Ravits J; Horner P; Misawa H; Yamanaka K
    Acta Neuropathol Commun; 2016 Feb; 4():15. PubMed ID: 26891847
    [TBL] [Abstract][Full Text] [Related]  

  • 72. MicroNeurotrophins Improve Survival in Motor Neuron-Astrocyte Co-Cultures but Do Not Improve Disease Phenotypes in a Mutant SOD1 Mouse Model of Amyotrophic Lateral Sclerosis.
    Glajch KE; Ferraiuolo L; Mueller KA; Stopford MJ; Prabhkar V; Gravanis A; Shaw PJ; Sadri-Vakili G
    PLoS One; 2016; 11(10):e0164103. PubMed ID: 27716798
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Opposing effects of low and high-dose clozapine on survival of transgenic amyotrophic lateral sclerosis mice.
    Turner BJ; Rembach A; Spark R; Lopes EC; Cheema SS
    J Neurosci Res; 2003 Nov; 74(4):605-13. PubMed ID: 14598305
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Transcriptomic indices of fast and slow disease progression in two mouse models of amyotrophic lateral sclerosis.
    Nardo G; Iennaco R; Fusi N; Heath PR; Marino M; Trolese MC; Ferraiuolo L; Lawrence N; Shaw PJ; Bendotti C
    Brain; 2013 Nov; 136(Pt 11):3305-32. PubMed ID: 24065725
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Effects of the PPARgamma activator pioglitazone on p38 MAP kinase and IkappaBalpha in the spinal cord of a transgenic mouse model of amyotrophic lateral sclerosis.
    Shibata N; Kawaguchi-Niida M; Yamamoto T; Toi S; Hirano A; Kobayashi M
    Neuropathology; 2008 Aug; 28(4):387-98. PubMed ID: 18312546
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Spinal cord pathology is ameliorated by P2X7 antagonism in a SOD1-mutant mouse model of amyotrophic lateral sclerosis.
    Apolloni S; Amadio S; Parisi C; Matteucci A; Potenza RL; Armida M; Popoli P; D'Ambrosi N; Volonté C
    Dis Model Mech; 2014 Sep; 7(9):1101-9. PubMed ID: 25038061
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Olesoxime delays muscle denervation, astrogliosis, microglial activation and motoneuron death in an ALS mouse model.
    Sunyach C; Michaud M; Arnoux T; Bernard-Marissal N; Aebischer J; Latyszenok V; Gouarné C; Raoul C; Pruss RM; Bordet T; Pettmann B
    Neuropharmacology; 2012 Jun; 62(7):2346-52. PubMed ID: 22369784
    [TBL] [Abstract][Full Text] [Related]  

  • 78. The CB2 cannabinoid agonist AM-1241 prolongs survival in a transgenic mouse model of amyotrophic lateral sclerosis when initiated at symptom onset.
    Shoemaker JL; Seely KA; Reed RL; Crow JP; Prather PL
    J Neurochem; 2007 Apr; 101(1):87-98. PubMed ID: 17241118
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Calcitonin gene-related peptide expression levels predict motor neuron vulnerability in the superoxide dismutase 1-G93A mouse model of amyotrophic lateral sclerosis.
    Ringer C; Weihe E; Schütz B
    Neurobiol Dis; 2012 Jan; 45(1):547-54. PubMed ID: 21964254
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Clemastine Confers Neuroprotection and Induces an Anti-Inflammatory Phenotype in SOD1(G93A) Mouse Model of Amyotrophic Lateral Sclerosis.
    Apolloni S; Fabbrizio P; Parisi C; Amadio S; Volonté C
    Mol Neurobiol; 2016 Jan; 53(1):518-531. PubMed ID: 25482048
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.